270 related articles for article (PubMed ID: 16006182)
21. Peptide aptamers as guides for small-molecule drug discovery.
Baines IC; Colas P
Drug Discov Today; 2006 Apr; 11(7-8):334-41. PubMed ID: 16580975
[TBL] [Abstract][Full Text] [Related]
22. Pharmacophore guided discovery of small-molecule human apurinic/apyrimidinic endonuclease 1 inhibitors.
Zawahir Z; Dayam R; Deng J; Pereira C; Neamati N
J Med Chem; 2009 Jan; 52(1):20-32. PubMed ID: 19072053
[TBL] [Abstract][Full Text] [Related]
23. A structure-based approach to drug discovery; crystallography and implications for the development of antiparasite drugs.
Hunter WN
Parasitology; 1997; 114 Suppl():S17-29. PubMed ID: 9309766
[TBL] [Abstract][Full Text] [Related]
24. Rational drug design via intrinsically disordered protein.
Cheng Y; LeGall T; Oldfield CJ; Mueller JP; Van YY; Romero P; Cortese MS; Uversky VN; Dunker AK
Trends Biotechnol; 2006 Oct; 24(10):435-42. PubMed ID: 16876893
[TBL] [Abstract][Full Text] [Related]
25. Structure-activity relationship homology (SARAH): a conceptual framework for drug discovery in the genomic era.
Frye SV
Chem Biol; 1999 Jan; 6(1):R3-7. PubMed ID: 9889153
[TBL] [Abstract][Full Text] [Related]
26. Informatics and modeling challenges in fragment-based drug discovery.
Hubbard RE; Chen I; Davis B
Curr Opin Drug Discov Devel; 2007 May; 10(3):289-97. PubMed ID: 17554855
[TBL] [Abstract][Full Text] [Related]
27. Advances in glycogen phosphorylase inhibitor design.
Oikonomakos NG; Somsák L
Curr Opin Investig Drugs; 2008 Apr; 9(4):379-95. PubMed ID: 18393105
[TBL] [Abstract][Full Text] [Related]
28. Ranking poses in structure-based lead discovery and optimization: current trends in scoring function development.
Rajamani R; Good AC
Curr Opin Drug Discov Devel; 2007 May; 10(3):308-15. PubMed ID: 17554857
[TBL] [Abstract][Full Text] [Related]
29. Key factors for successful generation of protein-fragment structures requirement on protein, crystals, and technology.
Böttcher J; Jestel A; Kiefersauer R; Krapp S; Nagel S; Steinbacher S; Steuber H
Methods Enzymol; 2011; 493():61-89. PubMed ID: 21371587
[TBL] [Abstract][Full Text] [Related]
30. Using X-ray crystallography in drug discovery.
Rowland RS
Curr Opin Drug Discov Devel; 2002 Jul; 5(4):613-9. PubMed ID: 12197319
[TBL] [Abstract][Full Text] [Related]
31. Applications of LC/MS in structure identifications of small molecules and proteins in drug discovery.
Chen G; Pramanik BN; Liu YH; Mirza UA
J Mass Spectrom; 2007 Mar; 42(3):279-87. PubMed ID: 17295416
[TBL] [Abstract][Full Text] [Related]
32. Protein-protein interactions as targets for small molecule drug discovery.
Fry DC
Biopolymers; 2006; 84(6):535-52. PubMed ID: 17009316
[TBL] [Abstract][Full Text] [Related]
33. Structure-based drug design to the discovery of new 2-aminothiazole CDK2 inhibitors.
Vulpetti A; Casale E; Roletto F; Amici R; Villa M; Pevarello P
J Mol Graph Model; 2006 Mar; 24(5):341-8. PubMed ID: 16260160
[TBL] [Abstract][Full Text] [Related]
34. Automation of X-ray crystallography.
Abola E; Kuhn P; Earnest T; Stevens RC
Nat Struct Biol; 2000 Nov; 7 Suppl():973-7. PubMed ID: 11104004
[TBL] [Abstract][Full Text] [Related]
35. Protein models in drug discovery.
Norin M; Sundström M
Curr Opin Drug Discov Devel; 2001 May; 4(3):284-90. PubMed ID: 11560059
[TBL] [Abstract][Full Text] [Related]
36. Form follows function: shape analysis of protein cavities for receptor-based drug design.
Weisel M; Proschak E; Kriegl JM; Schneider G
Proteomics; 2009 Jan; 9(2):451-9. PubMed ID: 19142949
[TBL] [Abstract][Full Text] [Related]
37. Fragment-based screening using X-ray crystallography and NMR spectroscopy.
Jhoti H; Cleasby A; Verdonk M; Williams G
Curr Opin Chem Biol; 2007 Oct; 11(5):485-93. PubMed ID: 17851109
[TBL] [Abstract][Full Text] [Related]
38. Recent trends in library design: 'rational design' revisited.
Schnur DM
Curr Opin Drug Discov Devel; 2008 May; 11(3):375-80. PubMed ID: 18428091
[TBL] [Abstract][Full Text] [Related]
39. Protein crystallization for structure-based drug design.
Hoffman ID
Methods Mol Biol; 2012; 841():67-91. PubMed ID: 22222449
[TBL] [Abstract][Full Text] [Related]
40. Preparation of protein crystals for X-ray structural study.
Takeda S
Methods Mol Med; 2006; 129():291-303. PubMed ID: 17085819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
